12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga · 06/02 21:05
Gainers
- Theriva Biologics (AMEX:TOVX) stock moved upwards by 47.4% to $0.72 during Monday's after-market session. The market value of their outstanding shares is at $5.8 million.
- MoonLake (NASDAQ:MLTX) shares moved upwards by 15.95% to $47.75. The company's market cap stands at $3.0 billion.
- FibroGen (NASDAQ:FGEN) shares rose 8.91% to $0.32. The company's market cap stands at $32.3 million.
- Owlet (NYSE:OWLT) stock rose 8.19% to $6.6. The company's market cap stands at $109.0 million.
- Instil Bio (NASDAQ:TIL) shares moved upwards by 7.92% to $32.0. The market value of their outstanding shares is at $209.9 million.
- Talphera (NASDAQ:TLPH) shares rose 7.27% to $0.51. The company's market cap stands at $10.4 million.
Losers
- ModivCare (NASDAQ:MODV) stock fell 22.7% to $1.7 during Monday's after-market session. The market value of their outstanding shares is at $24.4 million.
- Adlai Nortye (NASDAQ:ANL) shares fell 17.82% to $1.43. The company's market cap stands at $52.7 million.
- Clene (NASDAQ:CLNN) stock declined by 16.29% to $4.1. The market value of their outstanding shares is at $36.8 million.
- Rapport Therapeutics (NASDAQ:RAPP) shares decreased by 7.65% to $8.7. The company's market cap stands at $317.5 million.
- Unicycive Therapeutics (NASDAQ:UNCY) stock decreased by 7.1% to $0.62. The market value of their outstanding shares is at $74.2 million.
- Baird Medical Investment (NASDAQ:BDMD) stock fell 7.03% to $4.1. The market value of their outstanding shares is at $151.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.